4CPS-084 Identification of patient candidates to switch from tenofovir/emtricitabine to abacavir/lamivudine antiretroviral therapy: economic saving

BACKGROUND: The increase in life expectancy in patients receiving antiretroviral therapy (ART) and the incorporation of new drugs into the market, significantly increases the cost associated with the treatment of human immunodeficiency virus (HIV). Therefore, it would be a convenient optimisation of...

Full description

Saved in:
Bibliographic Details
Published in:Eur J Hosp Pharm
Main Authors: Moreno-Garcia, M, Castellano-Herrador, JJ, Madrid-Gonzalez, M, Ramis-Riera, X, Santos-Pérez, M, Prada-Lobato, J, Rodriguez-Barbero, J
Format: Artigo
Language:Inglês
Published: BMJ Group 2018
Subjects:
Section 4: Clinical pharmacy services
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535446/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.175
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items